Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · IEX Real-Time Price · USD
6.50
-0.57 (-8.00%)
At close: Jul 19, 2024, 4:30 PM
6.41
-0.09 (-1.38%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Burning Rock Biotech Revenue

Burning Rock Biotech had revenue of $72.30M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $17.45M. In the year 2023, Burning Rock Biotech had annual revenue of $75.80M.

Revenue (ttm)
$72.30M
Revenue Growth
-12.90%
P/S Ratio
0.92
Revenue / Employee
$91,982
Employees
786
Market Cap
66.59M USD

Revenue Chart

* The company reports in CNY currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202375.80M-5.01M-6.20%
Dec 31, 202280.81M1.46M1.83%
Dec 31, 202179.35M13.62M20.72%
Dec 31, 202065.73M11.21M20.56%
Dec 31, 201954.53M24.30M80.39%
Dec 31, 201830.23M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Precision BioSciences 57.53M
Champions Oncology 50.16M
Pro-Dex 49.46M
Celularity 14.79M
Milestone Scientific 9.48M
Revenue Rankings